Black Rose Indus

- Rs. 8 Crores capex planned for manufacturing Acrylamide powder (3600 tons capacity) at existing Jhagadia plant; expected revenue potential ~Rs. 65 Crores. - Additional capex expected for N-Methylol Acrylamide (NMA) product which is currently in lab and piloting stages; exact figures to be determined post-piloting. - Polyacrylamide solid plant (10000 tons capacity) under implementation; no clear timeline but R&D and piloting ongoing. - Future capital raises will be considered as per project requirements; no current announcements on new capital raising. - Expansion plans include scaling existing product lines when utilization nears 80-90%, with potential new chemical projects being evaluated. - Strategy prioritizes faster commercialization products like NMA and Acrylamide solids over polyacrylamide solid due to lower gestation period and existing client demand.

- Black Rose Industries aims to achieve peak revenues of Rs.150 Crores from Acrylamide (20,000 tons capacity) and Rs.100 Crores from PAM liquid (40,000 tons capacity), based on current pricing. - The company targets revenue of Rs.650 Crores by FY2023, comprising Rs.150 Crores from Acrylamide, Rs.100 Crores from PAM liquid, Rs.200 Crores from PAM solids, and Rs.200 Crores from distribution. - Acrylamide capacity utilization was 100% in Q3 FY2021, with a focus on increasing export volumes, especially to the US market. - PAM liquid is focused on ceramic binder applications with utilization around 25%; potential exists in textile, paper, and other segments. - Polyacrylamide solids project is still under R&D and will proceed once technical issues are resolved. - New products like N-Methylol Acrylamide (NMA) with 2000 tons capacity target Rs.30-50 Crores revenue and import substitution opportunities. - Expansion plans depend on achieving 80-90% capacity utilization; company will explore new chemical space opportunities over 3-5 years.

- Black Rose Industries aims to achieve peak revenues of approximately Rs. 650 Crores by FY2023, comprising Rs.150 Crores from Acrylamide, Rs.100 Crores from PAM liquid, Rs.200 Crores from PAM solids, and Rs.200 Crores from distribution. - Capacity utilization improvements, particularly from export growth, are expected to boost revenues, with Acrylamide expanded to 20,000 tons and PAM liquid at 40,000 tons capacity. - Margins are currently sustainable but subject to raw material price fluctuations and COVID-19 impacts; efforts to improve operational efficiencies are ongoing. - New products like N-Methylol Acrylamide (NMA) and Acrylamide solids are prioritized for quicker market capture and additional earnings. - The company expects to maintain or improve EBITDA margins, with profitability scaling alongside volume increases, higher realizations, and cost savings. - Continuous quarterly and annual disclosures will keep investors updated on performance and growth trajectory.

- The transcript does not explicitly mention the current or expected order book or pending orders by exact figures. - However, it was stated that in Q3, the company operated at close to 100% of its expanded merchant sales capacity of 20,000 metric tons due to very large orders in that particular month. - Exports, particularly to the US market, have started to pick up again after previous slowdowns caused by factors like oil price crashes and increased logistics costs. - The company is focusing on increasing export volumes for Acrylamide to boost capacity utilization in FY2022. - Large orders and improved export demand indicate a strong order book momentum but no specific quantitative details on pending orders were given. - The company remains cautious about market uncertainties caused by COVID-19 variants and lockdowns which could impact order flows.

- As of the May 31, 2021 earnings call, Black Rose Industries Limited did not have any immediate plans for capital raising. - The management indicated they would consider raising capital only when the need arises. - Several projects and discussions related to potential capital raising are ongoing at the board and senior management levels. - Any announcements about fundraising through debt or equity will be communicated to investors in due course. - No specific timelines or amounts for future fundraising were disclosed during the call.